Clinical Trials List
Protocol NumberMK-0663-098
Not yet recruiting
2009-01-01 - 2009-12-31
Phase III
Terminated2
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳世銓 Division of Anesthesia
- 黃鐙樂 Division of Orthopedics
- Yi-Chin Fong Division of Orthopedics
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
713 participants
